China Universal Asset Management Company’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Buy |
|
|||||
|
2025
Q1 | $419K | Sell |
|
|||||
|
2024
Q4 | $547K | Buy |
|
|||||
|
2024
Q3 | $349K | Buy |
|
|||||
|
2024
Q2 | $203K | Sell |
|
|||||
|
2024
Q1 | $435K | Buy |
|
|||||
|
2023
Q4 | $238K | Buy |
|
|||||
|
2023
Q3 | $40.1K | Buy |
|
|||||
|
2023
Q2 | $18.1K | Sell |
|
|||||
|
2023
Q1 | $16.6K | Buy |
|
|||||
|
2022
Q4 | $14.2K | Buy |
|
|||||
|
2022
Q3 | $16K | Buy |
|